Given the pharmacological significance of quinazoline pharmacophore and the growing importance of HDAC inhibitors in cancer treatment, we herein compiled the drug design and activity of quinazoline based dual inhibitors targeting HDAC enzyme with itself and other therapeutic targets such as PI3K, EGFR, VEGFR, and G9a/GLPand will be fully discussed in the following sections. This evidence concerns the gene KDR and cancer.